CSX Corp: Form 10-Q for the period ended Mar 28, 2014
Filed with the SEC on Apr 16, 2014 and accepted by EDGAR at Apr 16, 2014, 19:55 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-03-28. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2013-12-28 to 2014-03-28 | $3.01bn | us-gaap:SalesRevenueNet |
| Operating income | 3 months2013-12-28 to 2014-03-28 | $739.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2013-12-28 to 2014-03-28 | $140.0m | us-gaap:InterestExpense |
| Income tax | 3 months2013-12-28 to 2014-03-28 | $208.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2013-12-28 to 2014-03-28 | $398.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2013-12-28 to 2014-03-28 | $0.40 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2013-12-28 to 2014-03-28 | $0.40 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2013-12-28 to 2014-03-28 | 1,008,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2013-12-28 to 2014-03-28 | $599.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2013-12-28 to 2014-03-28 | $475.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2013-12-28 to 2014-03-28 | $151.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2013-12-28 to 2014-03-28 | $127.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2014-03-28 | $475.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-03-28 | $2.29bn | us-gaap:AssetsCurrent |
| Total assets | At period end2014-03-28 | $31.68bn | us-gaap:Assets |
| Current liabilities | At period end2014-03-28 | $2.21bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2014-03-28 | $21.04bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2014-03-28 | $10.64bn | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |
| Shares outstanding | At period end2014-03-28 | 1,004,362,589 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000277948-14-000018. Last ingested by Listed: Nov 4, 2026, 17:13 ET. Listed shows no prices and gives no investment advice.